| A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification (NCT02100475) | Novo Nordisk A/S | 2014-04-01 |
| A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes (NCT02119819) | OPKO Health, Inc. | 2014-04-01 |
| Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT03281083) | Duke-NUS Graduate Medical School | 2014-03-28 |
| Randomized Control Trial for Overweight Employees in Worksites (NCT03249610) | Diabetes Foundation, India | 2014-03-11 |
| Incretin-based Drugs and Pancreatic Cancer (NCT02475499) | Canadian Network for Observational Drug Effect Studies, CNODES | 2014-03-01 |
| Incretin-based Drugs and Acute Pancreatitis (NCT02476760) | Canadian Network for Observational Drug Effect Studies, CNODES | 2014-03-01 |
| Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content (NCT02383238) | University of Erlangen-Nürnberg Medical School | 2014-03-01 |
| Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin (NCT02111967) | University Hospital, Basel, Switzerland | 2014-03-01 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus (NCT02000700) | Janssen Research & Development, LLC | 2014-03-01 |
| Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (NCT02065791) | Janssen Research & Development, LLC | 2014-02-17 |
| A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (NCT01991795) | AstraZeneca | 2014-02-10 |
| A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden (NCT02077946) | Novo Nordisk A/S | 2014-02-10 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes (NCT02054897) | Novo Nordisk A/S | 2014-02-03 |
| Effects of Physical Activity Coaching on Health and Behaviour Parameters in Diabetic Persons (NCT02064335) | Universitaire Ziekenhuizen KU Leuven | 2014-02-01 |
| E4E-Health Professional Education for Improving Care for Canadian Aboriginal Populations (NCT01989962) | Queen's University | 2014-02-01 |
| A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes (NCT02053272) | Jazz Pharmaceuticals | 2014-02-01 |
| A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) (NCT02072096) | Eli Lilly and Company | 2014-02-01 |
| Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus (NCT02317211) | Sun Yat-sen University | 2014-02-01 |
| A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin (NCT02025907) | Janssen Research & Development, LLC | 2014-02-01 |
| Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus (NCT03552991) | Samsung Medical Center | 2014-02-01 |
| A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus (NCT01989754) | Janssen Research & Development, LLC | 2014-01-16 |
| Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2) (NCT03792321) | University Medical Centre Ljubljana | 2014-01-10 |
| Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes (NCT01917656) | Novo Nordisk A/S | 2014-01-09 |
| A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (NCT02030600) | Novo Nordisk A/S | 2014-01-06 |
| Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease (NCT03103854) | Cambridge Cardiac Care Centre | 2014-01-01 |
| Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population (NCT02012972) | Boston University | 2014-01-01 |
| Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome (NCT02015988) | Koval' O., MD | 2014-01-01 |
| Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes (NCT02910141) | King's College London | 2014-01-01 |
| Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment (NCT02026310) | Qifu Li | 2014-01-01 |
| Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery (NCT01970462) | Kathleen Dungan | 2014-01-01 |
| Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients (NCT02008942) | PLx Pharma | 2014-01-01 |
| Plant-Based Dietary Intervention in Type 2 Diabetes-2 (NCT01931631) | Physicians Committee for Responsible Medicine | 2014-01-01 |
| Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) (NCT02969798) | The University of Texas Health Science Center at San Antonio | 2014-01-01 |
| Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients (NCT01975935) | University of Michigan | 2014-01-01 |
| Serum METRNL Concentration in Type 2 Diabetes (NCT03194100) | Chungnam National University Hospital | 2014-01-01 |
| Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects (NCT02022254) | Novo Nordisk A/S | 2013-12-17 |
| Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment (NCT02016911) | Novo Nordisk A/S | 2013-12-12 |
| Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function (NCT02014259) | Novo Nordisk A/S | 2013-12-11 |
| Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes (NCT01923181) | Novo Nordisk A/S | 2013-12-02 |
| Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin (NCT01907854) | Novo Nordisk A/S | 2013-12-02 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes (NCT01930188) | Novo Nordisk A/S | 2013-12-02 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes (NCT01885208) | Novo Nordisk A/S | 2013-12-02 |
| Variation of Glucose Values at Early Stages of Diabetes - Continuous Glucose Monitoring (NCT02294370) | Folkhälsan Researech Center | 2013-12-01 |
| Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy (NCT02027753) | Sanofi | 2013-12-01 |
| A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes (NCT01995656) | Eli Lilly and Company | 2013-12-01 |
| A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin (NCT01951183) | Hoffmann-La Roche | 2013-12-01 |
| The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes (NCT02008682) | Novo Nordisk A/S | 2013-12-01 |
| Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus (NCT01821846) | Novo Nordisk A/S | 2013-11-20 |
| Mechanisms of Diabetic Kidney Disease in American Indians (NCT01878045) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2013-11-07 |
| Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba® (NCT01984372) | Novo Nordisk A/S | 2013-11-06 |
| Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms (NCT01892124) | University of Washington | 2013-11-01 |
| Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients (NCT01761318) | Leiden University Medical Center | 2013-11-01 |
| Partners in Care With Semi-Structured Support Group (NCT02144909) | University of Hawaii | 2013-11-01 |
| Post-prandial Glucose and Insulin Levels in Type 2 Diabetes Mellitus Patients After Consumption of Ready-to-eat Mixed Meals (NCT02543684) | Harokopio University | 2013-11-01 |
| A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events (NCT01959529) | Novo Nordisk A/S | 2013-10-29 |
| Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes (NCT01973231) | Novo Nordisk A/S | 2013-10-01 |
| PDT and Periodontal Treatment in DMT2 Patients (NCT01964833) | University of Nove de Julho | 2013-10-01 |
| Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease (NCT02001480) | RWTH Aachen University | 2013-10-01 |
| Study to Explore the Effects of Probiotics on Endotoxin Levels in Type 2 Diabetes Mellitus Patients (NCT01765517) | King Saud University | 2013-10-01 |
| Optimizing Behavioral Health Homes for Adults With Serious Mental Illness (NCT02318797) | University of Pittsburgh | 2013-10-01 |
| Comparing Strategies for Translating Self-management Support Into Primary Care (NCT01945918) | University of Colorado, Denver | 2013-10-01 |
| Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents (NCT01939496) | Janssen Scientific Affairs, LLC | 2013-10-01 |
| An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry (NCT01892319) | Novo Nordisk A/S | 2013-09-30 |
| Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes (NCT01850615) | Novo Nordisk A/S | 2013-09-23 |
| A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (NCT01952145) | Novo Nordisk A/S | 2013-09-20 |
| Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes (NCT01819129) | Novo Nordisk A/S | 2013-09-09 |
| Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics (NCT02402985) | German Institute of Human Nutrition | 2013-09-01 |
| Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus (NCT01947855) | Boehringer Ingelheim | 2013-09-01 |
| A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia (NCT01934673) | Novo Nordisk A/S | 2013-09-01 |
| Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients (NCT02012465) | Washington University School of Medicine | 2013-09-01 |
| A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia (NCT01934686) | Novo Nordisk A/S | 2013-09-01 |
| Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe (NCT01890993) | Novo Nordisk A/S | 2013-08-01 |
| Cardiovascular Oscillations in Coronary Patients With and Without Type 2 Diabetes (NCT02050399) | Universidade Federal de Sao Carlos | 2013-08-01 |
| The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus (NCT04253431) | HTL-Strefa S.A. | 2013-08-01 |
| A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects (NCT01916174) | Novo Nordisk A/S | 2013-08-01 |
| Time Efficient Exercise in Type 2 Diabetes (NCT02340260) | Norwegian University of Science and Technology | 2013-08-01 |
| Screening, Brief Intervention, and Referral to Treatment in Primary Care (NCT01966432) | Duke University | 2013-08-01 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin (NCT01929863) | GlaxoSmithKline | 2013-08-01 |
| Amlexanox for Type 2 Diabetes and Obesity (NCT01842282) | University of Michigan | 2013-07-19 |
| A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea (NCT01903356) | Boehringer Ingelheim | 2013-07-11 |
| Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) (NCT01897532) | Boehringer Ingelheim | 2013-07-10 |
| Diabetes Nutrition Algorithm - Prediabetes (NCT02609243) | German Institute of Human Nutrition | 2013-07-01 |
| Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period (NCT01900834) | Novo Nordisk A/S | 2013-07-01 |
| Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes (NCT02236481) | Prof. Roberto Giacomelli | 2013-07-01 |
| PMS of Trazenta on the Long-term Use as Add-on Therapy (NCT01904383) | Boehringer Ingelheim | 2013-07-01 |
| Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics (NCT02769585) | Levenson, David I., M.D. | 2013-07-01 |
| A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise (NCT01809327) | Janssen Research & Development, LLC | 2013-06-04 |
| A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes (NCT01849289) | Novo Nordisk A/S | 2013-06-02 |
| Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes (NCT01834274) | Takeda | 2013-06-01 |
| Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus (NCT01892020) | Novo Nordisk A/S | 2013-06-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus (NCT01874483) | Boehringer Ingelheim | 2013-06-01 |
| Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control (NCT02117154) | University of Malaya | 2013-06-01 |
| SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD (NCT01954771) | Beijing Anzhen Hospital | 2013-06-01 |
| Interprofessional Community-Based Diabetes Intervention for Older Adults (NCT01880476) | McMaster University | 2013-06-01 |
| A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy (NCT01871428) | Hoffmann-La Roche | 2013-06-01 |
| A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh (NCT01877200) | Novo Nordisk A/S | 2013-06-01 |
| A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes (NCT01880736) | Novo Nordisk A/S | 2013-06-01 |
| Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM) (NCT01889667) | Oramed, Ltd. | 2013-06-01 |
| Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls (NCT01867307) | Boehringer Ingelheim | 2013-06-01 |
| A Study of Multiple Doses of LY2922470 in Participants With Diabetes (NCT01867216) | Eli Lilly and Company | 2013-06-01 |